Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AFATINIB Cause Therapy partial responder? 73 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Therapy partial responder have been filed in association with AFATINIB (Gilotrif). This represents 1.2% of all adverse event reports for AFATINIB.

73
Reports of Therapy partial responder with AFATINIB
1.2%
of all AFATINIB reports
20
Deaths
12
Hospitalizations

How Dangerous Is Therapy partial responder From AFATINIB?

Of the 73 reports, 20 (27.4%) resulted in death, 12 (16.4%) required hospitalization.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AFATINIB. However, 73 reports have been filed with the FAERS database.

What Other Side Effects Does AFATINIB Cause?

Diarrhoea (2,001) Malignant neoplasm progression (1,622) Rash (808) Stomatitis (468) Death (443) Nausea (430) Decreased appetite (412) Vomiting (381) Paronychia (344) Dehydration (323)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which AFATINIB Alternatives Have Lower Therapy partial responder Risk?

AFATINIB vs AFINITOR AFATINIB vs AFLIBERCEPT AFATINIB vs AGALSIDASE ALFA AFATINIB vs AGALSIDASE BETA AFATINIB vs AGOMELATINE

Related Pages

AFATINIB Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder AFATINIB Demographics